Singapore - English - HSA (Health Sciences Authority)

welch allyn singapore pte. ltd. - cardiovascular - • device is indicated for use to acquire, analyze, display, and print electrocardiograms. • device is indicated for use to provide interpretation of the data for consideration by a physician. • device is indicated for use in a clinical setting, by a physician or by trained personnel who are acting on the orders of a licensed physician. it is not intended as a sole means of diagnosis. • the interpretations of ecg offered by the device are only significant when used in conjunction with a physician over-read as well as consideration of all other relevant patient data. • device is indicated for use on adult and pediatric populations. • the device is not intended to be used as a vital signs physiological monitor.

Singapore - English - HSA (Health Sciences Authority)

welch allyn singapore pte. ltd. - cardiovascular - the h3+ is indicated for use in a clinical setting, by qualified medical professionals only, for recording ecg data of patients requiring ambulatory (holter) monitoring of up to 48 hours. such monitoring is most frequently used for the purpose of prospective and retrospective cardiac data and arrhythmia analysis. holter analysis is appropriate for the indications: evaluation of adult patients with symptoms suggesting arrhythmia; evaluation of adult patients with pacemakers; reporting of time domain heart rate variability; evaluation of a patient’s response after resuming occupational or recreational activities (e.g., after m.i. or cardiac surgery); evaluation of ecg documenting therapeutic interventions in individual patients or groups of patients; clinical and epidemiological research studies and infant patient evaluation is limited to qrs detection only.

Singapore - English - HSA (Health Sciences Authority)

welch allyn singapore pte. ltd. - cardiovascular - the q-stress device is intended to acquire, process, record, archive, analyze, and output electrocardiographic data during physiologic stress testing. the device is intended for use in adult, adolescent, and children patient populations. the device is intended for use in a clinical setting by trained personnel under the supervision of a licensed physician. the device may interface with equipment for pulmonary function testing and other devices, including a treadmill or ergometer for dynamic exercise evaluation, as well as non-invasive blood pressure equipment, functional arterial oxygen saturation (spo2) equipment, and computer communications equipment. the device is not intended to be used as a vital signs physiological monitor.

Singapore - English - HSA (Health Sciences Authority)

welch allyn singapore pte. ltd. - general hospital - it provides remote viewing of patient vital signs.

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

care limited, tanzania - wheelchair -

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

care limited, tanzania - wheelchair -

Singapore - English - HSA (Health Sciences Authority)

welch allyn singapore pte. ltd. - cardiovascular - the h12+ holter recorder is intended to acquire, record and store ecg data of patients that have been connected to the h12+ recorder and are undergoing holter monitoring. the h12+ acquires, digitizes and stores data to be analyzed by the hscribe holter system. the h12+ is indicated for use in a clinical setting, by qualified medical professionals only, for recording ecg data of symptomatic patients requiring ambulatory (holter) monitoring of up to 48 hours. the h12+ does not perform cardiac analysis by itself and is intended to be used with the hscribe™ holter analysis system. ecg data pre-recorded by the h12+ is acquired and analyzed by the hscribe holter analysis system.

Singapore - English - HSA (Health Sciences Authority)

welch allyn singapore pte. ltd. - general hospital - the connex spot monitors are intended to be used by clinicians and medically qualified personnel for monitoring of noninvasive blood pressure, pulse rate, noninvasive functional oxygen saturation of arteriolar hemoglobin (spo2) and body temperature in normal and axillary modes of neonatal, pediatric and adult patients. monitoring respiration rate from photophlethysmogram (masimo rrp) is indicated for adult and pediatric patients greater than two years old.

United States - English - NLM (National Library of Medicine)

leadiant biosciences, inc. - amphotericin b (unii: 7xu7a7droe) (amphotericin b - unii:7xu7a7droe), dimyristoylphosphatidylcholine, dl- (unii: u86zgc74v5) (dimyristoylphosphatidylcholine, dl- - unii:u86zgc74v5), dimyristoylphosphatidylglycerol, dl- (unii: bi71wt9p3r) (dimyristoylphosphatidylglycerol, dl- - unii:bi71wt9p3r) - amphotericin b 5 mg in 1 ml - abelcet ® is indicated for the treatment of invasive fungal infections in patients who are refractory to or intolerant of conventional amphotericin b therapy. this is based on open-label treatment of patients judged by their physicians to be intolerant to or failing conventional amphotericin b therapy (see description of clinical studies). description of clinical studies fungal infections data from 473 patients were pooled from three open-label studies in which abelcet ® was provided for the treatment of patients with invasive fungal infections who were judged by their physicians to be refractory to or intolerant of conventional amphotericin b, or who had preexisting nephrotoxicity. results of these studies demonstrated effectiveness of abelcet ® in the treatment of invasive fungal infections as a second line therapy. patients were defined by their individual physician as being refractory to or failing conventional amphotericin b therapy based on overall clinical judgement after receiving a minimu

Australia - English - Department of Health (Therapeutic Goods Administration)

mobility plus wheelchairs - 14449 - wheelchair, - foldable rehab stroller for disabled children